Demonstrating faster, simpler, more cost-efficient NGS workflows that turn complex agrigenomics data into practical ...

Explore the groundbreaking AI genomics platform, Inference, launched by Variant Bio to enhance drug discovery using genetic ...

Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug dis ...

Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic ...

After raising $33 million in just 15 seconds, Shivom has entered into partnership with SingularityNet, in order to combine blockchain, AI and genomic research in order to achieve advanced, ...

The Mystra platform, developed over 10 years, offers biopharma partners proven analytical power to turn months of R&D into minutes, dramatically increasing the availability of quality genetic insights ...

KNOXVILLE, TN, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- Daisy Genomics Inc. (“Daisy Genomics”) and New Day ...

LAKE FOREST, Calif.--(BUSINESS WIRE)--Genomic Testing Cooperative (GTC), a leader in advanced genomic testing, announced the launch of GTC Interpret, a new web-based platform designed to provide Co-Op ...

Transaction combines Sema4’s leading AI- and machine learning-powered integrated genomic and clinical open-architecture data platform, with CM Life Sciences, the leading life science-focused SPAC, led ...

SAN DIEGO, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and ...

OncoLens and The Jackson Laboratory Launch Program to Expand Molecular Tumor Boards to Community Oncology Centers ...

WuXi NextCODE closed a $240 million Series B financing round. Sequoia China led the funding round. WuXi NextCODE is a global platform for genomic data. It will use the funds to extend platform ...